These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18613837)

  • 1. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.
    Ware CF
    Immunol Rev; 2008 Jun; 223():186-201. PubMed ID: 18613837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.
    Steinberg MW; Cheung TC; Ware CF
    Immunol Rev; 2011 Nov; 244(1):169-87. PubMed ID: 22017438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells.
    De Trez C; Schneider K; Potter K; Droin N; Fulton J; Norris PS; Ha SW; Fu YX; Murphy T; Murphy KM; Pfeffer K; Benedict CA; Ware CF
    J Immunol; 2008 Jan; 180(1):238-48. PubMed ID: 18097025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the LIGHT-HVEM pathway.
    Ware CF
    Adv Exp Med Biol; 2009; 647():146-55. PubMed ID: 19760072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
    Cai G; Freeman GJ
    Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.
    Bechill J; Muller WJ
    Mol Immunol; 2014 Nov; 62(1):96-103. PubMed ID: 24980868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting.
    Pasero C; Truneh A; Olive D
    Curr Mol Med; 2009 Sep; 9(7):911-27. PubMed ID: 19860669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
    Cheung TC
    Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
    Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
    J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.
    De Trez C; Ware CF
    Cytokine Growth Factor Rev; 2008; 19(3-4):277-84. PubMed ID: 18511331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.
    Cheung TC; Humphreys IR; Potter KG; Norris PS; Shumway HM; Tran BR; Patterson G; Jean-Jacques R; Yoon M; Spear PG; Murphy KM; Lurain NS; Benedict CA; Ware CF
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13218-23. PubMed ID: 16131544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
    Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
    J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
    Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
    J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unconventional ligand activation of herpesvirus entry mediator signals cell survival.
    Cheung TC; Steinberg MW; Oborne LM; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6244-9. PubMed ID: 19332782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.
    Šedý JR; Bjordahl RL; Bekiaris V; Macauley MG; Ware BC; Norris PS; Lurain NS; Benedict CA; Ware CF
    J Immunol; 2013 Jul; 191(2):828-36. PubMed ID: 23761635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and characterization of TNFSF14 (LIGHT) and its receptor TNFRSF14 (HVEM) in guinea pig (Cavia porcellus).
    Li C; Chen S; Song J; Liu H; Gu W; Ai H; Zhao B; Zhang S
    Gene; 2013 Sep; 526(2):374-84. PubMed ID: 23732292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.
    Zhang M; Howard K; Winters A; Steavenson S; Anderson S; Smelt S; Doellgast G; Sheelo C; Stevens J; Kim H; Hamburger A; Sein A; Caughey DJ; Lee F; Hsu H; Siu G; Byrne FR
    Clin Exp Immunol; 2011 Jan; 163(1):77-87. PubMed ID: 21078085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M; Sedy J; Nelson CA; Murphy KM
    Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.